ClinicalTrials.Veeva

Menu
U

University of South Alabama | Surgery Department

Research site
(Unclaimed)

Site insights

Top conditions

Top treatments

Gemcitabine
Elagolix
Carboplatin
Paclitaxel
Estradiol
Acetaminophen
Veliparib
ABBV-951
ARQ 501
Dexlansoprazole

Curious how this site stacks up to its peers?

Data sourced from clinicaltrials.gov

Work at this site?

CTV for research professionals allows users to enhance their site’s profile, add contact information, and more.

Learn more and claim site

Active trials

7 of 98 total trials

A Study Evaluating the Efficacy and Safety of Multiple Therapies in Cohorts of Participants With Locally Advanced, Unresectable, Stage III Non-Small Cell Lung Cancer (NSCLC)

This study will evaluate the efficacy and safety of multiple therapies in participants with locally advanced, unresectable, Stage III NSCLC with elig...

Enrolling
Non-Small Cell Lung Cancer
Drug: Durvalumab
Drug: Entrectinib

Gastroesophageal reflux disease (GERD) is caused by food or acid coming up from the stomach into the esophagus, repeatedly. The esophagus is the tube...

Enrolling
Erosive Esophagitis
Drug: Dexlansoprazole

Gastroesophageal reflux disease (GERD) is caused by food or acid coming up from the stomach into the esophagus, repeatedly. The esophagus is the tube...

Enrolling
Gastroesophageal Reflux Disease (GERD)
Drug: Dexlansoprazole

This is a multicenter, open-label, single-arm Phase II study to evaluate anti-tumor efficacy and safety of NT-I7 in combination with atezolizumab in...

Active, not recruiting
Non-Small Cell Lung Carcinoma
Nonsmall Cell Lung Cancer
Drug: efineptakin alfa
Drug: Atezolizumab

This prospective, multi-center, randomized, controlled clinical trial is being conducted to evaluate the safety and efficacy of the pdSTIM System to...

Enrolling
Ventilator Induced Diaphragm Dysfunction
Device: pdSTIM System Therapy

This study is designed to identify the target Non-Small Cell Lung Cancer (NSCLC) population(s) that overexpress c-Met (c-Met+) best suited for teliso...

Active, not recruiting
Non-small Cell Lung Cancer
Drug: Telisotuzumab vedotin

Parkinson's disease (PD) is a neurological condition, which affects the brain. PD gets worse over time, but how quickly it progresses varies a lot fr...

Active, not recruiting
Parkinson's Disease (PD)
Drug: ABBV-951

Trial sponsors

AbbVie logo
U
Braintree Laboratories logo
Actelion Pharmaceuticals logo
C
S
Takeda logo
E
Gilead Sciences logo
Medtronic logo

Clinical trials

Find clinical trialsTrials by location
© Copyright 2025 Veeva Systems